NPY and postural orthostatic tachycardia syndrome: These findings suggest that LL‐TS may offer a therapeutic approach for reductions in upright heart rate response, alterations in autonomic imbalance, and decreases in NPY levels in individuals with POTS induced by post‐acute COVID‐19.